Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alaa-Eldin F Nassar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|March 24, 2004
Strategies for dealing with metabolite elucidation in drug discovery and developmentAlaa-Eldin F Nassar, Rasmy E Talaat
Current Opinion in Drug Discovery & Development|February 26, 2004
Strategies for dealing with reactive intermediates in drug discovery and developmentAlaa-Eldin F Nassar, Arturo Lopez-Anaya
Idrugs : the Investigational Drugs Journal|December 26, 2006
Drug interactions: concerns and current approachesAlaa-Eldin F Nassar, Rasmy E Talaat, Hajime Tokuno
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2016
Biotransformation and Rearrangement of LaromustineAlaa-Eldin F Nassar, Adam V Wisnewski, Ivan King
Drug Discovery Today|December 3, 2004
Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stabilityAlaa-Eldin F Nassar, Amin M Kamel, Caroline Clarimont
Drug Discovery Today|December 8, 2004
Improving the decision-making process in structural modification of drug candidates: reducing toxicityAlaa-Eldin F Nassar, Amin M Kamel, Caroline Clarimont
Current Opinion in Drug Discovery & Development|February 1, 2006
The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?Alaa-Eldin F Nassar, Rasmy E Talaat, Amin M Kamel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 13, 2009
An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymesAlaa-Eldin F Nassar, Ivan King, Brandy L Paris, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|March 24, 2004
Strategies for dealing with metabolite elucidation in drug discovery and developmentAlaa-Eldin F Nassar, Rasmy E Talaat
Current Opinion in Drug Discovery & Development|February 26, 2004
Strategies for dealing with reactive intermediates in drug discovery and developmentAlaa-Eldin F Nassar, Arturo Lopez-Anaya
Idrugs : the Investigational Drugs Journal|December 26, 2006
Drug interactions: concerns and current approachesAlaa-Eldin F Nassar, Rasmy E Talaat, Hajime Tokuno
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2016
Biotransformation and Rearrangement of LaromustineAlaa-Eldin F Nassar, Adam V Wisnewski, Ivan King
Drug Discovery Today|December 3, 2004
Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stabilityAlaa-Eldin F Nassar, Amin M Kamel, Caroline Clarimont
Drug Discovery Today|December 8, 2004
Improving the decision-making process in structural modification of drug candidates: reducing toxicityAlaa-Eldin F Nassar, Amin M Kamel, Caroline Clarimont
Current Opinion in Drug Discovery & Development|February 1, 2006
The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?Alaa-Eldin F Nassar, Rasmy E Talaat, Amin M Kamel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 13, 2009
An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymesAlaa-Eldin F Nassar, Ivan King, Brandy L Paris, et al.
Pageof 1